trending Market Intelligence /marketintelligence/en/news-insights/trending/jsnjh56_n5d-1idwwoom0q2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Motif Bio board member resigns

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Motif Bio board member resigns

New York-based Motif Bio PLC said Robert Bertoldi will step down from its board, effective July 16.

Motif Bio is a clinical stage biopharmaceutical company that develops and sells pharmaceutical formulations in the U.S.